Drug · CHEMBL29
PENICILLIN G
7 sourcespipelines-2026-09-18-0.3.1
Cite this record
ConductScience Library. PENICILLIN G. Drugs and targets, record CHEMBL29. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL29
On this page
Drug
Names and IDs as ChEMBL gives them, through Open Targets.
- Other names
- Bencilpenicilina, Benzyl penicillin, Benzylpenicillin, Benzylpenicilline, J01CE01, NSC-193396
- ChEMBL
Targets0
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
None in this release.
Diseases17
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
1 to 10 of 17Source Open Targets
See all 17 diseasesTrials19
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs. 7 more rest on that reading alone and are shown because the trials' posted result groups or NLM's indexing of their papers name the drug. 10 more that Open Targets linked to it are not shown, since the release's checks do not confirm them.
| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT03637660 | Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection | Phase 4 | 249 | 2023-12-26 | benzathine penicillin G | Open Targets' reading, confirmed by the trial's result groups and NLM's indexing of its papers | ClinicalTrials.gov |
| NCT02611765 | Syphilis Response to Higher Penicillin Dosage: The 2.4 Versus 7.2 Study | Phase 4 | 64 | 2016-04-11 | benzathine penicillin G | Open Targets' reading, confirmed by the trial's result groups and NLM's indexing of its papers | ClinicalTrials.gov |
| NCT03660488 | Cefixime for Alternative Syphilis Treatment | Phase 2 | 58 | 2022-07-26 | benzathine penicillin g | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT03174236 | First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition | Phase 3 | 2,000 | benzyl penicillin | Its name | ClinicalTrials.gov | |
| NCT05693545 | GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial | Phase 2 | 1,004 | benzathine penicillin g | Open Targets' reading, confirmed by NLM's indexing of its papers | ClinicalTrials.gov | |
| NCT03346525 | Determining the Impact of Penicillin in Latent RHD: The GOAL Trial | Phase 2 | 807 | benzathine penicillin G | Open Targets' reading, confirmed by NLM's indexing of its papers | ClinicalTrials.gov | |
| NCT00031499 | Azithromycin/Bicillin Syphilis | Phase 3 | 593 | benzathine penicillin G | Open Targets' reading, confirmed by NLM's indexing of its papers | ClinicalTrials.gov | |
| NCT01156740 | Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings | 558 | penicillin g | Its name | ClinicalTrials.gov | ||
| NCT06726395 | Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia | Phase 4 | 420 | benzylpenicillin | Its name | ClinicalTrials.gov | |
| NCT04876131 | Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children | Phase 4 | 396 | benzylpenicillin | Its name | ClinicalTrials.gov |
1 to 10 of 19
See all 19 trialsComparisons in its trials0
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
None in this release.
Papers from its trials0
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
None in this release.
Tests in its trials0
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
None in this release.
Data dates
The date of each source this release read.
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this drug from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL29
GET https://conductscience.org/api/drugs/v1/CHEMBL29/targets